Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Gastric Cancer
and you are
between 18 and 100
years old
The phase for this study is not defined.
Show me locations

The purpose

Background. Gastric cancer surgery is associated with high risk for postoperative morbidity and mortality. Anastomotic leak (AL) is one of the worst complications associated with relevant short and long-term sequelae. Procalcitonin (PCT) is a biomarker used to monitor bacterial infections and guide antibiotic therapy and has been shown to have better predictive value of AL after colorectal surgery than C-reactive protein (CRP) and white blood cell count (WBC). Purpose. Investigators designed a monocentric pilot study to test if PCT might be a sensitive and reliable marker of AL after gastric surgery

Provided treatments

  • Other: gastric cancer pts undergoing surgery
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02756455. The sponsor of the trial is University of Roma La Sapienza and it is looking for 100 volunteers for the current phase.
Official trial title:
Procalcitonin Reveals Early Dehiscence In Gastric Surgery: the PREDIGS Study